Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L van Alphen

Showing results (101-110 of 131) with videos related to

Pageof 14
Sort By:
Clinical and Diagnostic Laboratory Immunology|July 1, 1994
Quantitative flow cytometric analysis of opsonophagocytosis and killing of nonencapsulated Haemophilus influenzae by human polymorphonuclear leukocytesL Vogel, L van Alphen, F Geluk, et al.
Infection and Immunity|July 1, 1995
Binding of Haemophilus influenzae to purified mucins from the human respiratory tractJ Davies, I Carlstedt, A K Nilsson, et al.
Journal of Clinical Microbiology|October 1, 1989
Nonculture detection of Haemophilus influenzae in sputum with monoclonal antibodies specific for outer membrane lipoprotein P6K Groeneveld, L van Alphen, R J van Ketel, et al.
Vaccine|August 7, 2004
PorA-specific differences in antibody avidity after vaccination with a hexavalent Men B outer membrane vesicle vaccine in toddlers and school childrenC L Vermont, H H Van Dijken, R De Groot, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|November 1, 1989
Carriage of Haemophilus influenzae in healthy Gambian childrenH A Bijlmer, N L Evans, H Campbell, et al.
Vaccine|March 16, 2007
Enhanced decision support for policy makers using a web interface to health-economic models--illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the NetherlandsG A A Hubben, J M Bos, D M Glynn, et al.
Vaccine|December 9, 2008
Incorporation of LpxL1, a detoxified lipopolysaccharide adjuvant, in influenza H5N1 virosomes increases vaccine immunogenicityJ J C de Vries, L Bungener, W Ter Veer, et al.
Infection and Immunity|April 22, 2003
Functional activity of antibodies against the recombinant OpaJ protein from Neisseria meningitidisM I de Jonge, G Vidarsson, H H van Dijken, et al.
Antimicrobial Agents and Chemotherapy|January 30, 1999
Variation in the composition and pore function of major outer membrane pore protein P2 of Haemophilus influenzae from cystic fibrosis patientsA G Regelink, D Dahan, L V Möller, et al.
Infection and Immunity|July 19, 2000
Cloning of genes of nontypeable Haemophilus influenzae involved in penetration between human lung epithelial cellsM van Schilfgaarde, P van Ulsen, W van Der Steeg, et al.
Pageof 14

Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
Clinical and Diagnostic Laboratory Immunology|July 1, 1994
Quantitative flow cytometric analysis of opsonophagocytosis and killing of nonencapsulated Haemophilus influenzae by human polymorphonuclear leukocytesL Vogel, L van Alphen, F Geluk, et al.
Infection and Immunity|July 1, 1995
Binding of Haemophilus influenzae to purified mucins from the human respiratory tractJ Davies, I Carlstedt, A K Nilsson, et al.
Journal of Clinical Microbiology|October 1, 1989
Nonculture detection of Haemophilus influenzae in sputum with monoclonal antibodies specific for outer membrane lipoprotein P6K Groeneveld, L van Alphen, R J van Ketel, et al.
Vaccine|August 7, 2004
PorA-specific differences in antibody avidity after vaccination with a hexavalent Men B outer membrane vesicle vaccine in toddlers and school childrenC L Vermont, H H Van Dijken, R De Groot, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|November 1, 1989
Carriage of Haemophilus influenzae in healthy Gambian childrenH A Bijlmer, N L Evans, H Campbell, et al.
Vaccine|March 16, 2007
Enhanced decision support for policy makers using a web interface to health-economic models--illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the NetherlandsG A A Hubben, J M Bos, D M Glynn, et al.
Vaccine|December 9, 2008
Incorporation of LpxL1, a detoxified lipopolysaccharide adjuvant, in influenza H5N1 virosomes increases vaccine immunogenicityJ J C de Vries, L Bungener, W Ter Veer, et al.
Infection and Immunity|April 22, 2003
Functional activity of antibodies against the recombinant OpaJ protein from Neisseria meningitidisM I de Jonge, G Vidarsson, H H van Dijken, et al.
Antimicrobial Agents and Chemotherapy|January 30, 1999
Variation in the composition and pore function of major outer membrane pore protein P2 of Haemophilus influenzae from cystic fibrosis patientsA G Regelink, D Dahan, L V Möller, et al.
Infection and Immunity|July 19, 2000
Cloning of genes of nontypeable Haemophilus influenzae involved in penetration between human lung epithelial cellsM van Schilfgaarde, P van Ulsen, W van Der Steeg, et al.
Pageof 14